as on September 15, 2025 at 7:36 pm IST
Day's Low
Day's High
-0.07%
Downside
1.50%
Upside
52 Week's Low
52 Week's High
24.59%
Downside
12.11%
Upside
Check Abrdn Life Sciences Investors market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$409.1M
EPS (TTM)
0Dividend Yield
10.48%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0Return On Equity TTM
27363400.00%
Compare market cap, revenue, PE, and other key metrics of Abrdn Life Sciences Investors with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
NA | $409.1M | -20.62% | NA | 0.00% | |
BUY | $132.7B | 297.84% | 67.61 | 9.57% | |
HOLD | $222.7B | 245.71% | 49.01 | 21.20% | |
BUY | $174.0B | 104.94% | 27.17 | 29.69% | |
BUY | $101.4B | NA | 154.09 | 1.07% |
The Abrdn Life Sciences Investors stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Abrdn Life Sciences Investors investment value today
Current value as on today
₹96,543
Returns
Returns from Abrdn Life Sciences Investors Stock
Dollar Returns*
₹4,985 (+4.99%)
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 1.91M → 18.19M (in $), with an average increase of 89.5% per quarter
Against Peers
In the last 3 years, Kkr & Co. L.p. has given 38.9% return, outperforming this stock by 43.2%
Against Peers
In the last 1 year, Brookfield Corp has given 37.3% return, outperforming this stock by 44.6%
Price Dip
In the last 1 year, HQL stock has moved down by -7.3%
Profit Down
Netprofit is down for the last 3 quarters, 50.25M → -47.23M (in $), with an average decrease of 132.5% per quarter
Organisation | Abrdn Life Sciences Investors |
Headquarters | 1900 Market Street, Philadelphia, PA, United States, 19103 |
Industry | Financial |
CEO | Dr. Daniel R. Omstead M.S, Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Daniel R. Omstead M.S, Ph.D. | Principal Executive Officer, President and Trustee |
Mr. Peter Branner | Chief Investment Officer |
Abrdn Life Sciences Investors share price today is $13.99 as on . Abrdn Life Sciences Investors share today touched a day high of $14.2 and a low of $14.
Abrdn Life Sciences Investors share touched a 52 week high of $15.68 on and a 52 week low of $10.55 on . Abrdn Life Sciences Investors stock price today i.e. is trending at $13.99,which is 10.80% down from its 52 week high and 32.61% up from its 52 week low.
Abrdn Life Sciences Investors market capitalisation is $0.00T as on .
Indian investors can start investing in Abrdn Life Sciences Investors (HQL) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Abrdn Life Sciences Investors stock (as per the Rupee-Dollar exchange rate as on ).
Based on Abrdn Life Sciences Investors share’s latest price of $13.99 as on September 15, 2025 at 7:36 pm IST, you will get 0.7148 shares of Abrdn Life Sciences Investors. Learn more about
fractional shares .
Abrdn Life Sciences Investors stock has given -20.62% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?